Hepatocellular carcinoma‑cavernous hemangioma collision tumor: A case report

Wu,Shiheng; Zhang,Xinxing; Bao,Jin; Sun,Naiying; Guo,Wenjun; Wang,Baogui; Yang,Xingjie

doi:10.3892/ol.2023.14207

Hepatocellular carcinoma‑cavernous hemangioma collision tumor: A case report

Authors:
- Shiheng Wu
- Xinxing Zhang
- Jin Bao
- Naiying Sun
- Wenjun Guo
- Baogui Wang
- Xingjie Yang
View Affiliations

Affiliations: Department of Infectious Diseases, Fuyang People's Hospital, Fuyang, Anhui 236000, P.R. China, Department of Imaging Center, Sunshine Union Hospital, Weifang, Shandong 261000, P.R. China, Department of Pathology, Fangzi People's Hospital, Weifang, Shandong 261200, P.R. China, Department of Pathology, Sunshine Union Hospital, Weifang, Shandong 261000, P.R. China
Published online on: December 22, 2023 https://doi.org/10.3892/ol.2023.14207
Article Number: 74
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Collision tumors consisting of hepatocellular carcinoma (HCC) and cavernous hemangioma (CH) are rare and the clinicopathological characteristics or cause of the tumors remain unclear. The present study reports the case of a 71‑year‑old male patient who was admitted to Sunshine Union Hospital (Weifang, China) due to a liver mass found during a routine physical examination. Computed tomography scans showed a main lesion of ~4.0x4.2x3.5 cm in segment IV of the patient's liver and a nodule of ~2.4x2.2x1.3 cm in the lower‑left part of the lesion, which was clearly demarcated from the main lesion. The capsule of the lesion was found to be intact during the operation performed to remove the tumor. The final patient diagnosis was of a HCC‑CH collision tumor based on pathology. The patient underwent follow‑up for 6 months after surgery and no recurrence was observed.

View Figures

View References

1	Palomino MZ, Caicedo-Holguín I, Pardo S, Mera AT, Gómez AP and Zorrilla JO: Case report: Tumor collision in the colon, adenocarcinoma-lymphoma. Int J Surg Case Rep. 98:1075732022. View Article : Google Scholar : PubMed/NCBI
2	Montealegre RA and Barrera JC: Combined mohs micrographic surgery in a collision tumor. Cureus. 14:e267472022.PubMed/NCBI
3	Choe AR, Shim KN, Lim J, Song EM, Tae CH, Jung SA and Jo MS: A collision tumor of the esophagus: Mixed squamous cell carcinoma and neuroendocrine carcinoma. Korean J Gastroenterol. 75:207–211. 2020. View Article : Google Scholar : PubMed/NCBI
4	Yılmaz DB, Bayramoğlu Z, Ünay G, Ayık E, Başsorgun Cİ and Elpek GÖ: Incidental collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma. J Clin Transl Hepatol. 6:339–344. 2018. View Article : Google Scholar : PubMed/NCBI
5	Jeng KS, Huang CC, Chung CS and Chang CF: Liver collision tumor of primary hepatocellular carcinoma and neuroendocrine carcinoma: A rare case report. World J Clin Cases. 10:13129–13137. 2022. View Article : Google Scholar : PubMed/NCBI
6	Choi GH, Ann SY, Lee SI, Kim SB and Song IH: Collision tumor of hepatocellular carcinoma and neuroendocrine carcinoma involving the liver: Case report and review of the literature. World J Gastroenterol. 22:9229–9234. 2016. View Article : Google Scholar : PubMed/NCBI
7	Nishino H, Hatano E, Seo S, Shibuya S, Anazawa T, Iida T, Masui T, Taura K, Haga H and Uemoto S: Histological features of mixed neuroendocrine carcinoma and hepatocellular carcinoma in the liver: A case report and literature review. Clin J Gastroenterol. 9:272–279. 2016. View Article : Google Scholar : PubMed/NCBI
8	Nakano A, Hirabayashi K, Yamamuro H, Mashiko T, Masuoka Y, Yamamoto S, Ozawa S and Nakagohri T: Combined primary hepatic neuroendocrine carcinoma and hepatocellular carcinoma: Case report and literature review. World J Surg Oncol. 19:782021. View Article : Google Scholar : PubMed/NCBI
9	Garcia MT, Bejarano PA, Yssa M, Buitrago E and Livingstone A: Tumor of the liver (hepatocellular and high grade neuroendocrine carcinoma): A case report and review of the literature. Virchows Arch. 449:376–381. 2006. View Article : Google Scholar : PubMed/NCBI
10	Ge XW, Zeng HY, Su-Jie A, Du M, Ji Y, Tan YS, Hou YY and Xu JF: Hepatocellular carcinoma with concomitant hepatic angiomyolipoma and cavernous hemangioma in one patient. World J Gastroenterol. 21:3414–3419. 2015. View Article : Google Scholar : PubMed/NCBI
11	Noh BG, Seo HI, Park YM, Kim S, Hong SB and Lee SJ: Complete resection of large-cell neuroendocrine and hepatocellular carcinoma of the liver: A case report. World J Clin Cases. 10:8277–8283. 2022. View Article : Google Scholar : PubMed/NCBI
12	Gao YX, Ning QQ, Yang PX, Guan YY, Liu PX, Liu ML, Qiao LX, Guo XH, Yang TW and Chen DX: Recent advances in recurrent hepatocellular carcinoma therapy. World J Hepatol. 15:460–476. 2023. View Article : Google Scholar : PubMed/NCBI
13	Lazzaro A and Hartshorn KL: A comprehensive narrative review on the history, current landscape, and future directions of hepatocellular carcinoma (HCC) systemic therapy. Cancers (Basel). 15:25062023. View Article : Google Scholar : PubMed/NCBI
14	Fischer AK, Beckurts KTE, Büttner R and Drebber U: Giant cavernous hemangioma of the liver with satellite nodules: Aspects on tumour/tissue interface: A case report. World J Hepatol. 15:707–714. 2023. View Article : Google Scholar : PubMed/NCBI
15	Kanda T, Goto T, Hirotsu Y, Moriyama M and Omata M: Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis b and c infections: A Review. Int J Mol Sci. 20:13582019. View Article : Google Scholar : PubMed/NCBI
16	Russo FP, Zanetto A, Pinto E, Battistella S, Penzo B, Burra P and Farinati F: Hepatocellular carcinoma in chronic viral hepatitis: Where do we stand? Int J Mol Sci. 23:5002022. View Article : Google Scholar : PubMed/NCBI
17	Wang C and Cui F: Expanded screening for chronic hepatitis B virus infection in China. Lancet Glob Health. 10:e171–e172. 2022. View Article : Google Scholar : PubMed/NCBI
18	Yang J, Qi JL, Wang XX, Li XH, Jin R, Liu BY, Liu HX and Rao HY: The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019. Front Public Health. 11:10412012023. View Article : Google Scholar : PubMed/NCBI
19	Tamaoka K, Tanemura M, Furukawa K, Mikamori M, Saito T, Ohtsuka M, Suzuki Y, Tei M, Kishi K, Yasuoka H, et al: Primary intrahepatic squamous cell carcinoma with histological collision of adenocarcinoma and squamous cell carcinoma: A case report. Am J Case Rep. 19:1184–1191. 2018. View Article : Google Scholar : PubMed/NCBI
20	Kim E and Viatour P: Hepatocellular carcinoma: Old friends and new tricks. Exp Mol Med. 52:1898–1907. 2020. View Article : Google Scholar : PubMed/NCBI
21	Hu S, Lyu X, Li W, Cui X, Liu Q, Xu X, Wang J, Chen L, Zhang X and Yin Y: Radiomics analysis on noncontrast CT for distinguishing hepatic hemangioma (HH) and hepatocellular carcinoma (HCC). Contrast Media Mol Imaging. 2022:76936312022. View Article : Google Scholar : PubMed/NCBI
22	Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, et al: CHANCE001 Investigators: Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal Transduct Target Ther. 8:582023. View Article : Google Scholar : PubMed/NCBI